On July 29, 2021, the company will present new data from a phase 2 trial with simufilam, a potential first-in-class stabilizer of a structural protein called filamin A. On July 29 or before that i expect the stock to touch $150 where it would make it ATH and a new top and reverse. I would be looking to close longs take a short at that point for a reversal to below $100.